GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Total Assets

CLVSF (CellaVision AB) Total Assets : $96.18 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Total Assets?

CellaVision AB's Total Assets for the quarter that ended in Sep. 2024 was $96.18 Mil.

Warning Sign:

If a company builds assets at 26.4% a year, faster than its revenue growth rate of 12.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, CellaVision AB's average Total Assets Growth Rate was 3.70% per year. During the past 3 years, the average Total Assets Growth Rate was 12.60% per year. During the past 5 years, the average Total Assets Growth Rate was 26.40% per year. During the past 10 years, the average Total Assets Growth Rate was 26.10% per year.

During the past 13 years, CellaVision AB's highest 3-Year average Total Assets Growth Rate was 65.80%. The lowest was -4.90%. And the median was 13.20%.

Total Assets is connected with ROA %. CellaVision AB's annualized ROA % for the quarter that ended in Sep. 2024 was 12.98%. Total Assets is also linked to Revenue through Asset Turnover. CellaVision AB's Asset Turnover for the quarter that ended in Sep. 2024 was 0.19.


CellaVision AB Total Assets Historical Data

The historical data trend for CellaVision AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Total Assets Chart

CellaVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.03 79.88 90.79 85.93 90.54

CellaVision AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.69 90.54 93.56 91.29 96.18

CellaVision AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

CellaVision AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=69.84+20.699
=90.54

CellaVision AB's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=75.067+21.114
=96.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellaVision AB  (OTCPK:CLVSF) Total Assets Explanation

Total Assets is connected with ROA %.

CellaVision AB's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=12.168/( (91.285+96.181)/ 2 )
=12.168/93.733
=12.98 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

CellaVision AB's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=17.466/( (91.285+96.181)/ 2 )
=17.466/93.733
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

CellaVision AB Total Assets Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.

CellaVision AB Headlines